In the study, we investigated the expression of survivin and three ABC transporters in patients with DLBCL and analyzed correlations between IHC expression and clinicopathological parameters and their potential predictive values to the R-CHOP treatment response. The gene discussed is ABCG2; the disease is diffuse large B-cell lymphoma.